Free Trial

Cencora (COR) Competitors

Cencora logo
$288.31 +2.23 (+0.78%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$288.70 +0.38 (+0.13%)
As of 08/1/2025 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COR vs. ELV, MCK, CAH, HSIC, OMI, DHR, CVS, LH, NTRA, and ICLR

Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Elevance Health (ELV), McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Owens & Minor (OMI), Danaher (DHR), CVS Health (CVS), Labcorp (LH), Natera (NTRA), and ICON (ICLR). These companies are all part of the "medical" sector.

Cencora vs. Its Competitors

Cencora (NYSE:COR) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

Elevance Health has higher revenue and earnings than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cencora$638.56M87.51$1.51B$8.6233.45
Elevance Health$177.01B0.35$5.98B$23.5011.66

97.5% of Cencora shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 10.8% of Cencora shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.55%. Cencora's return on equity of 344.71% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cencora0.55% 344.71% 4.26%
Elevance Health 2.83%17.59%6.36%

In the previous week, Elevance Health had 5 more articles in the media than Cencora. MarketBeat recorded 38 mentions for Elevance Health and 33 mentions for Cencora. Cencora's average media sentiment score of 1.51 beat Elevance Health's score of 1.44 indicating that Cencora is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cencora
29 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Elevance Health
36 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 2.5%. Cencora pays out 25.5% of its earnings in the form of a dividend. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and Elevance Health has raised its dividend for 14 consecutive years.

Cencora has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.

Cencora presently has a consensus price target of $309.83, suggesting a potential upside of 7.47%. Elevance Health has a consensus price target of $418.19, suggesting a potential upside of 52.57%. Given Elevance Health's higher probable upside, analysts clearly believe Elevance Health is more favorable than Cencora.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cencora
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75
Elevance Health
0 Sell rating(s)
6 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Elevance Health beats Cencora on 10 of the 19 factors compared between the two stocks.

Get Cencora News Delivered to You Automatically

Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COR vs. The Competition

MetricCencoraMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$55.45B$7.18B$5.49B$20.63B
Dividend Yield0.75%2.90%4.73%3.67%
P/E Ratio33.4564.1328.8329.01
Price / Sales87.5133.83372.0766.10
Price / Cash14.3925.7735.4522.82
Price / Book71.368.618.274.43
Net Income$1.51B$239.96M$3.25B$993.74M
7 Day Performance-0.64%-5.48%-3.73%-3.39%
1 Month Performance-0.95%-3.73%4.29%-2.10%
1 Year Performance16.47%18.27%25.87%10.09%

Cencora Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COR
Cencora
4.3778 of 5 stars
$288.31
+0.8%
$309.83
+7.5%
+17.9%$55.45B$638.56M33.4546,000Positive News
Upcoming Earnings
ELV
Elevance Health
4.9528 of 5 stars
$284.91
-1.4%
$418.19
+46.8%
-48.5%$64.20B$189.25B12.13104,200Positive News
MCK
McKesson
4.5174 of 5 stars
$709.79
-0.3%
$710.17
+0.1%
+11.0%$88.76B$359.05B27.4745,000Positive News
Upcoming Earnings
Dividend Increase
CAH
Cardinal Health
4.685 of 5 stars
$156.05
-0.7%
$158.07
+1.3%
+50.8%$37.25B$226.83B24.3548,900Positive News
Analyst Downgrade
HSIC
Henry Schein
4.1329 of 5 stars
$71.23
-0.3%
$78.08
+9.6%
-6.6%$8.67B$12.67B22.2525,000Upcoming Earnings
OMI
Owens & Minor
4.6451 of 5 stars
$7.89
+0.1%
$11.60
+47.0%
-59.8%$609.12M$10.70B-1.6623,200Gap Down
DHR
Danaher
4.9712 of 5 stars
$204.11
-0.7%
$247.61
+21.3%
-29.8%$146.14B$24.01B43.4363,000Positive News
CVS
CVS Health
4.9985 of 5 stars
$60.16
-0.9%
$75.13
+24.9%
+4.2%$76.18B$372.81B14.37300,000Trending News
Earnings Report
Analyst Forecast
Options Volume
Analyst Revision
LH
Labcorp
4.8252 of 5 stars
$261.97
-1.1%
$285.00
+8.8%
+12.0%$21.96B$13.48B28.9670,000Insider Trade
NTRA
Natera
3.6987 of 5 stars
$138.75
-0.1%
$183.76
+32.4%
+30.7%$18.97B$1.70B-94.484,434Trending News
Upcoming Earnings
Insider Trade
ICLR
ICON
4.5302 of 5 stars
$188.14
+0.6%
$219.54
+16.7%
-49.1%$15.18B$8.28B19.3341,900

Related Companies and Tools


This page (NYSE:COR) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners